Research suggests that silymarin may help prevent glutathione depletion in the liver, ensuring that the organ remains capable of processing toxins efficiently
doi: 10.1203/01.PDR.0000242374.21415.f5 9 KimYMPaeHOParkJELeeYCWooJMKimNHet al
The following primary antibodies diluted in TBST (containing 4% gelatin and 3% BSA) were used: anti-DRP1 (#8570, 1:3000, Cell Signaling Technology), anti-p-DRP1 S616 (#3455S, 1:3000, Cell Signaling Technology), anti-p-DRP1 S637 (#4867S, 1:3000, Cell Signaling Technology), anti- GAPDH (#60004-1-Ig, 1:5000, Proteintech), anti-Cyclin B1 (#4138, 1:3000, Cell Signaling Technology), anti-p16 (#1002202-23, 1:2000, abcam), anti-p62 (#ab109012, 1:3000, abcam), anti-LC3B (#ab192890, 1:3000, abcam), anti-Pink1 (#23274-1-AP, 1:3000, Proteintech), anti-Beclin1 (11306-1-AP, 1:3000, Proteintech), anti-TFR2 (#A9845, 1:5000, ABclonal), anti-FTH1 (#A19544, 1:5000, ABclonal), anti-HO-1 (#10701-AP, 1:2000, Proteintech), anti-GPX4 (ab125066, 1:5000, Abcam), Anti-HSP60 (66041-1-Ig, 1:3000, Proteintech), anti-SLC7A11 (#26864-1-AP,1:3000, Proteintech), anti-SLC3A2 (#15193-1-AP, 1:3000, Proteintech), anti-NRF2 (#16396-1-AP, 1:3000, Proteintech), anti-BNIP3 (#68091-1-Ig, 1:3000, Proteintech) and anti-Parkin (#2132, 1:3000, Cell Signaling Technology)
The wMel wolbachia strain blocks dengue and invades caged aedes aegypti populations
Use In Pediatrics Consult your doctor The safety and effectiveness of GLUTAHENZ DT 1000MG TABLET in children is not established
